Back to search results

Improving Health for African American COVID-19 Survivors and Carepartners

This study is testing a program called iCINGS FAM to help African American adults who had COVID-19 and their carepartners. Many African Americans, especially in rural South Carolina, face higher rates of chronic diseases like diabetes and heart problems, which can make COVID-19 more severe. This program aims to improve health and quality of life by providing support and guidance from a nurse and community health worker team. The study will measure changes in participants' overall health using a survey called PROMIS Global Health Scale over seven months. We are looking for 500 participants who are African American, at least 18 years old, live in specific areas of South Carolina, had a COVID-19-related hospitalization or ER/Urgent Care visit, and have certain chronic health conditions. The study's current status is unclear.

Study design
This is an interventional study that plans to enroll 500 participants. It uses a randomized controlled trial design.
What's involved
Participants will have two planning sessions over two weeks, followed by eight topic-guided sessions with a nurse and community health worker team over 12 weeks. These sessions will be weekly for the first four weeks, then every other week.
Compensation
Not stated in the trial record.
Follow-up
Participants' health will be measured at the beginning of the study, at 4 months, and at 7 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05370014

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Recruiting
NAAges 18+InterventionalSupportive care
University of South Carolina
~500 participants
Updated 2025-05-16 on ClinicalTrials.gov
What's tested:Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in patient-reported outcomes measurement information system (PROMIS) Global Health Scale
Measured over 0, 4, 7 months

Conditions

SARS- CoV-2
Cardiovascular Diseases
Chronic Kidney Diseases
Diabetes Mellitus, Type 2
Chronic Disease
Stroke

Explore related trials

Cardiovascular DisorderChronic Kidney DiseaseCOVID-19 InfectionHypertensionStrokeType 2 Diabetes Mellitus

Where it's being run

1 sites across 1 states
South Carolina1

Study leadership

  • Gayenell S Magwood, PhD · PRINCIPAL_INVESTIGATOR · University of South Carolina

Who to contact

Study PI
[email protected]
8037779160
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

African American
Male and female
Living in a Medically Underserved Area and/or a designated rural area of South Carolina
≥ 18 years and above
A history of a COVID-19-associated hospitalization, ER or Urgent Care visit since March 11th, 2020
A previous diagnosis of one or more of the following conditions: type 2 diabetes, hypertension, cardiovascular disease, chronic kidney disease, or stroke (\>3 months)
Male and female
≥ 18 years and above
Must live on the same property or community, preferably within a 40-mile radius of the survivor
Primarily responsible for care provision and/or care/social support in the home (i.e., is not paid for services)

What this trial measures

  • Change in patient-reported outcomes measurement information system (PROMIS) Global Health Scale0, 4, 7 months

    Quality of Life 10 items. minimum score 4 to maximum score 20. Higher scores mean better.